ACERCA DE ESTE EPISODIO
In Part 1 of this two-part “Engaging the Experts” interview, William Zellmer talks with Edward Li and James Stevenson regarding the status of biosimilars in the European Union and United States.
Faculty:
Edward C. Li, Pharm.D., M.P.H., BCOP, Activity Chair
Associate Professor
Department of Pharmacy Practice
University of New England College of Pharmacy
Portland, Maine
James G. Stevenson, Pharm.D., FASHP
Professor, Department of Clinical Pharmacy
University of Michigan College of Pharmacy
President, Hospital and Health System Services
Visante, Inc.
Ann Arbor, Michigan
C.E. Credits: This activity is not eligible for continuing education credits.
Inglés
Estados Unidos
TRANSCRIPCIÓN 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
BUSCAR EPISODIOS ANTERIORES
Buscar episodios anteriores de ASHP Advantage's Engaging the Experts.
OTROS EPISODIOS EN ESTE PODCAST
Part 1: Barriers to Optimizing the Use of Insulin in Managing Type 2 Diabetes
In Part 1 of this two-part “Engaging the Experts” interview, William Zellmer talks with Curtis L. Triplitt, Susan Cornell, and Joshua J. Neumiller regarding the barriers to optimizing the use of insulin in managing pati…
William Zellmer talks with John Petrich and Michael Storey about gene therapies and considerations for integrating them into pharmacy practice.
In Part 2 of this two-part “Engaging the Experts” interview, William Zellmer talks with Edward Li and James Stevenson regarding biosimilars, focusing on interchangeability and the integration of biosimilars into the medication-use system.
Faculty:
Edward C. Li, Pharm.D., M.P.H., BCOP, Activity C…
Angela Cassano talks with Ryan Forrey about insourcing compounded sterile products and how he addressed the challenges faced at Emory University Hospital Midtown.
Part 2: Future Treatment Options and Roles for Pharmacists in Individualizing Insulin Therapy
In Part 2 of this two-part “Engaging the Experts” interview, William Zellmer talks with Curtis L. Triplitt, Susan Cornell, and Joshua J. Neumiller regarding future treatment options for type 2 diabete…
Descargo de responsabilidad: El podcast y el arte incluidos en esta página son de ASHP Advantage, que es propiedad de su propietario y no está afiliado ni respaldado por Listen Notes, Inc.
EDITAR
Gracias por ayudar a mantener actualizada la base de datos de podcasts.
